Arena obesity drug disappoints

Arena Pharmaceuticals said its experimental obesity drug helped patients shed only about 10 pounds more than those taking placebos, sending its shares down 34 percent. The company is seeking U.S. approval this year for the drug, Lorcaserin, based on the long-awaited new data that it said was favorable by a statistically significant margin. "Although the results technically satisfy the FDA requirements for approvability, we consider the weight loss benefits to be underwhelming at best," JPMorgan said in a research note. Patients on the drug and placebo groups had to adhere to a program of moderate diet and exercise.

Bonnie - let's get real. You can lose ten pounds on moderate diet and exercise easily. You don't need the drug!